MedTrace Logo

A Pilot Gaming Adherence Program for Youth Living With HIV

NCT01887210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2018-09-26

Study results available
· View outcomes & findings →

Summary

This study will develop and test a novel, technology based intervention to improve treatment adherence among youth living with HIV who are taking antiretroviral medication. In the intervention youth will access an engaging and immersive app/game on their smartphone.Data about the opening of the smart pill bottle will be transferred from the bottle cap wirelessly and will trigger a text message about their adherence. While gaming, participants will gain information about their health, improve motivation for ARV and medical appointment adherence, and practice healthy behaviors. If the Intervention is found to be effective, it can be tested in a larger study and then disseminated to other youth on antiretroviral medications.

Conditions

  • Adherence to HIV Treatment and Medication

Interventions

BEHAVIORAL

IMB Gaming Adherence Intervention

Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV

BEHAVIORAL

Enhanced treatment as usual

Smart pill bottle cap and mobile phone but no game

Sponsors & Collaborators

  • Rhode Island Hospital

    lead OTHER

Principal Investigators

  • Larry K Brown, MD · Rhode Island Hospital

  • Laura Whiteley, MD · Rhode Island Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-01-09
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01887210 on ClinicalTrials.gov